Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
Eur J Med Chem. 2020 Dec 1;207:112670. doi: 10.1016/j.ejmech.2020.112670. Epub 2020 Aug 5.
Eur J Med Chem. 2020.
PMID: 32858470
Review.
Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer.
Skarbek C, Serra S, Maslah H, Rascol E, Labruère R.
Skarbek C, et al. Among authors: maslah h.
Bioorg Chem. 2019 Oct;91:103158. doi: 10.1016/j.bioorg.2019.103158. Epub 2019 Jul 24.
Bioorg Chem. 2019.
PMID: 31376782
Item in Clipboard
Boronic acid/boronate prodrugs for cancer treatment: current status and perspectives.
Maslah H, Pethe S, Labruère R.
Maslah H, et al.
Future Med Chem. 2021 May;13(10):859-861. doi: 10.4155/fmc-2021-0037. Epub 2021 Apr 13.
Future Med Chem. 2021.
PMID: 33845596
No abstract available.
Item in Clipboard
In-Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development.
Maslah H, Skarbek C, Gourson C, Plamont MA, Pethe S, Jullien L, Le Saux T, Labruère R.
Maslah H, et al.
Angew Chem Int Ed Engl. 2021 Nov 2;60(45):24043-24047. doi: 10.1002/anie.202110041. Epub 2021 Oct 5.
Angew Chem Int Ed Engl. 2021.
PMID: 34487611
Item in Clipboard
Cite
Cite